|Day Low/High||55.08 / 55.85|
|52 Wk Low/High||53.12 / 66.41|
Economic conditions seem to be improving for laborers. Perhaps rapidly.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2017.
This Black History month we are taking a look at the African Americans who have made it to the C-Suite and are making a difference. And sadly, there are not many. Watch our video to learn the names you should know now.
BMO Capital Markets analyst Alex Arfaei says the fourth-quarter results show how dependent the drugmaker is on major diabetes assets 'and doesn't alleviate our concerns.'
With an estimated 1.6 million Americans diagnosed in 2017 alone, cancer not only impacts those diagnosed but their friends and family as well.
Here's what you need to know now for Tuesday, Jan. 30.
The most recent short interest data has been released for the 98/16/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
As earnings season continues, companies are taking investor calls as an opportunity to explain just what they have planned for their tax reform-related windfalls of cash.
Jim discusses GE, Comcast, Illinois Tool Works, and Abbott Labs, all of which reported earnings Wednesday morning.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that Inge Thulin, chairman of the board, president and chief executive officer of 3M, will join the company's board of directors effective...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.
With a boost from the NFL and its own IPO, Quanterix hopes to engage biopharma companies to use its platform to speed safety and efficacy results for neurology, oncology and inflammation pipelines.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced findings from the registrational phase 2 KEYNOTE-224 trial investigating the use of KEYTRUDA ® (pembrolizumab), the company's...
AstraZeneca and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Japanese Ministry of Health, Labour and Welfare has approved LYNPARZA ® (olaparib) tablets (300mg...
It's time again to visit with the latest charts and indicators.
They make more irrational, stupid moves based on nothing than I ever thought possible.
It might look easy now, but it looked easy in 1999, too.
The Dow Jones Industrial Average broke through 26,000 on Tuesday, but ended the day with a small loss. The S&P 500 and Nasdaq also finished lower.
Merck said a Phase 3 study of its immuno-oncology drug Keytruda in tandem with chemotherapy drugs pemetrexed (Alimta) and cisplatin or carboplatin was successful.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending topics.
The Dow Jones Industrial Average breaks through 26,000 on Tuesday, and the S&P 500 crosses 2,800. Both indexes, along with the Nasdaq, set record intraday highs.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the pivotal Phase 3 KEYNOTE-189 trial investigating KEYTRUDA ® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with...
The three major stock indexes finished at record highs on Friday.
AstraZeneca and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.
Healthcare executives meeting at JP Morgan Conference agree that new tax reform is good, but how it will impact the sector is not yet entirely clear.
Consider that MRK analysts are projecting earnings growth this year and next.
A study of analyst recommendations at the major brokerages shows that Merck & Co Inc is the #11 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Merck & Co Inc also comes in above the median of analyst picks among the broader S&P 500 index components, claiming the #194 spot out of 500.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and The European Organisation for Research and Treatment of Cancer (EORTC), today announced that the phase 3 EORTC1325/KEYNOTE-054 trial investigating...
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.